Skip to content

CONBIN

Active
Private limited companyfounded 20224 yrs activeVliegveld 43, 8560 Wevelgem, BelgiumKBO/BCE: BE 0789.987.992
Summary

CONBIN has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €168,594 and a net result of -€1,432. Equity is growing by ~6.5% per year across the filed fiscal years. Its solvency ranks better than 35% of 112 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.8% (low).

Checked score

Score 2025
Axes · tick = 2024
Profitability59▲+23
Solvency61▼-5
Growth52=
Track record94
Bankruptcy probability, 12 months
0.8% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €9,000 at 30 days acceptable
Liquidity short (current ratio 0.37 against 0.13 in 2024; short-term debt: 36.9% and cash: 0.1% of total assets), and 64.4% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Three signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 4 years 0 10 y
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 20
Relative position
BE, all sectors
reference
Manufacture of chemicals and chemical products (NACE 20)
about 43% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-07-2026, 4 days ahead of the deadline.
NBB · 3 filings
Deviation from the deadline
2025
4 d early
2024
26 d late
2023
26 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 3 accounts on average 16 days after the deadline; the sector median for financial year 2024 is 22 days before the deadline, and 27% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
28-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 25 August 2022, CONBIN was incorporated as a Private limited company.1 Of the 2 current board members, APHRODITES AMPHORA COSMETICS has served longest, since 2026.2 Total assets went from EUR 392,961 in 2023 to EUR 474,049 in 2025.3

  1. 1Crossroads Bank for Enterprises
  2. 2Belgian State Gazette, 27-08-2026
  3. 3National Bank, annual accounts 2023 and 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, abbreviated schema

Equity
€168,594▼ 0.8%
2024 · €170,026
Total assets
€474,049▲ 13.6%
2024 · €417,132
Net result
-€1,432▲ 51.6%
2024 · -€2,955
Working capital
-€109,453▼ 9.2%
2024 · -€100,243
Trend over the years

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 20, Manufacture of chemicals and chemical products, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before
favourable unfavourable
Line202320242025
Operating result€6,918--€420€194
Net result€4,622within the sector's middle half--€2,955below the sector's middle half-€1,432below the sector's middle half▲ 51.6%
Equity€146,622below the sector's middle half-€170,026below the sector's middle half▲ 16.0%€168,594within the sector's middle half▼ 0.8%
Total assets€392,961below the sector's middle half-€417,132below the sector's middle half▲ 6.2%€474,049within the sector's middle half▲ 13.6%
Debt€246,339-€247,106▲ 0.3%€305,455▲ 23.6%
Working capital-€93,255--€100,243▼ 7.5%-€109,453▼ 9.2%
Solvency37.3%within the sector's middle half-40.8%within the sector's middle half▲ 3.4pp35.6%within the sector's middle half▼ 5.2pp
Staff (FTE)0below the sector's middle half
above within below the middle half (P25 to P75) of NACE 20, Manufacture of chemicals and chemical products, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
-€5,000-€2,500€0€2,500€5,000€7,500Operating result 2023: €6,918€6,918Net result 2023: €4,622€4,622Operating result 2024: -€420-€420Net result 2024: -€2,955-€2,955Operating result 2025: €194€194Net result 2025: -€1,432-€1,432202320242025-€5,000-€2,500€0€2,500€5,000€7,500Operating result 2023: €6,918€6,920Net result 2023: €4,622€4,620Operating result 2024: -€420-€420Net result 2024: -€2,955-€2,960Operating result 2025: €194€194Net result 2025: -€1,432-€1,430202320242025
The operating result returns to profit in 2025: €194 after a loss of €420 in 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €474,049
Fixed assets €408,694 ▲ 1.7%
Current assets €65,355 ▲ 329%
Equity and liabilities €474,049
Equity €168,594 ▼ 0.8%
Debt €305,455 ▲ 23.6%
Debt's share of the balance-sheet total rises from 59.2% to 64.4%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€7,838▲
2024 · €5,699
Cash flow
€6,213▲
2024 · €3,163
Current ratio
0.37▲
2024 · 0.13
Debt to equity
1.81▲
2024 · 1.45
ROE
-0.8%▲
2024 · -1.7%
ROA
-0.3%▲
2024 · -0.7%
Interest coverage
4.82▲
2024 · 2.17
Debt ≤ 1 year
€174,808▲
2024 · €115,492
Debt > 1 year
€129,250=
2024 · €129,250
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 480 companies that looked in July 2024 the way this one looks now, 0.8% went bankrupt within 24 months and 96% are still going.

  • Small
  • 2 to 5 years old
  • solvency 30% or more
  • a small loss
0.8% went bankrupt
3.1% stopped otherwise
96% still going

A further 0.2% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of 0.8% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.4%
3 0.5% 0.5%
4 0.6% 0.7%
5 0.8% 0.9%
6 1.2% 1.3%
7 1.5% 1.7%
8 1.7% 1.7%
9 2.7% 2.8%
10 5.3% 5.7%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 480 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 51 lines
Balance sheet Code20242025
Assets
Total assets20/58€417,132€474,049▲
Fixed assets21/28€401,882€408,694▲
Tangible fixed assets22/27€401,882€408,694▲
Land and buildings22€395,213€404,546▲
Plant, machinery and equipment23€4,999€3,101▼
Furniture and vehicles24€1,671€1,047▼
Current assets29/58€15,250€65,355▲
Amounts receivable within one year40/41€12,251€64,455▲
Trade receivables40€2,358€63,160▲
Other amounts receivable41€9,892€1,295▼
Cash at bank and in hand54/58€2,913€553▼
Deferred charges and accrued income490/1€87€347▲
Equity and liabilities
Total equity and liabilities10/49€417,132€474,049▲
Equity10/15€170,026€168,594▼
Contributions10/11€145,000€145,000=
Revaluation surpluses12€26,359€26,359=
Reserves13€0-
Distributable reserves133€0-
Profit (loss) carried forward14-€1,333-€2,764▼
Amounts payable17/49€247,106€305,455▲
Amounts payable after more than one year17€129,250€129,250=
Financial debts170/4€129,250€129,250=
Amounts payable within one year42/48€115,492€174,808▲
Trade debts44€7,201€7,044▼
Suppliers440/4€7,201€7,044▼
Advances received on contracts in progress46€3,025€0▼
Taxes, remuneration and social security45€406€0▼
Taxes450/3€406€0▼
Other amounts payable47/48€104,860€167,764▲
Accrued charges and deferred income492/3€2,364€1,397▼
Income statement Code20242025
Non-recurring operating income76A€1,084€1,310▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€6,118€7,644▲
Other operating charges640/8€2,300€2,340▲
Gross operating margin9900€7,999€10,178▲
Operating profit (loss)9901-€420€194▲
Financial income75/76B€89€0▼
Recurring financial income75€89€0▼
Financial charges65/66B€2,624€1,625▼
Recurring financial charges65€2,624€1,625▼
Profit (loss) for the period before taxes9903-€2,955-€1,432▲
Income taxes67/77€0-
Profit (loss) for the period9904-€2,955-€1,432▲
Profit (loss) for the period to be appropriated9905-€2,955-€1,432▲
Appropriation of the result
Profit (loss) to be appropriated9906-€2,955-€2,764▲
Profit (loss) brought forward from the previous period14P--€1,333
Transfer from equity791/2€1,622€0▼
Transfer to equity691/2€0-
To the legal reserve6920€0-
Profit to be distributed694/7€0-
Directors or managers695€0-
Social balance
Average headcount (FTE)9087-0.0

The notes to these accounts (13 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line202320242025Change
Non-recurring operating income76A-€1,084€1,310▲ 20.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€29,317€6,118€7,644▲ 24.9%
Other operating charges640/8€1,118€2,300€2,340▲ 1.7%
Gross operating margin9900€37,353€7,999€10,178▲ 27.2%
Operating profit (loss)9901€6,918-€420€194▲ 146%
Financial income75/76B€38€89€0▼ 100%
Recurring financial income75€38€89€0▼ 100%
Financial charges65/66B€1,928€2,624€1,625▼ 38.1%
Recurring financial charges65€1,928€2,624€1,625▼ 38.1%
Profit (loss) for the period before taxes9903€5,028-€2,955-€1,432▲ 51.6%
Income taxes67/77€406€0--
Profit (loss) for the period9904€4,622-€2,955-€1,432▲ 51.6%
Profit (loss) for the period to be appropriated9905€4,622-€2,955-€1,432▲ 51.6%
Line202320242025Change
Assets
Total assets20/58€392,961€417,132€474,049▲ 13.6%
Fixed assets21/28€370,680€401,882€408,694▲ 1.7%
Tangible fixed assets22/27€370,680€401,882€408,694▲ 1.7%
Land and buildings22€364,086€395,213€404,546▲ 2.4%
Plant, machinery and equipment23€5,116€4,999€3,101▼ 38.0%
Furniture and vehicles24€1,478€1,671€1,047▼ 37.3%
Current assets29/58€22,281€15,250€65,355▲ 329%
Amounts receivable within one year40/41€14,036€12,251€64,455▲ 426%
Trade receivables40€3,617€2,358€63,160▲ 2,578%
Other amounts receivable41€10,419€9,892€1,295▼ 86.9%
Cash at bank and in hand54/58€8,245€2,913€553▼ 81.0%
Deferred charges and accrued income490/1-€87€347▲ 301%
Equity and liabilities
Total equity and liabilities10/49€392,961€417,132€474,049▲ 13.6%
Equity10/15€146,622€170,026€168,594▼ 0.8%
Contributions10/11€145,000€145,000€145,000=
Revaluation surpluses12-€26,359€26,359=
Reserves13€1,622€0--
Distributable reserves133€1,622€0--
Profit (loss) carried forward14€0-€1,333-€2,764▼ 107%
Amounts payable17/49€246,339€247,106€305,455▲ 23.6%
Amounts payable after more than one year17€129,250€129,250€129,250=
Financial debts170/4€129,250€129,250€129,250=
Amounts payable within one year42/48€115,536€115,492€174,808▲ 51.4%
Trade debts44€1,531€7,201€7,044▼ 2.2%
Suppliers440/4€1,531€7,201€7,044▼ 2.2%
Advances received on contracts in progress46-€3,025€0▼ 100%
Taxes, remuneration and social security45€406€406€0▼ 100%
Taxes450/3€406€406€0▼ 100%
Other amounts payable47/48€113,600€104,860€167,764▲ 60.0%
Accrued charges and deferred income492/3€1,552€2,364€1,397▼ 40.9%
Line202320242025Change
Profit (loss) for the period9904€4,622-€2,955-€1,432▲ 51.6%
+ Depreciation and write-downs630€29,317€6,118€7,644▲ 24.9%
Operating cash flow (approximation)€33,940€3,163€6,213▲ 96.4%
Investment in fixed assets (approximation)--€37,321-€14,456▲ 61.3%
Change in cash--€5,332-€2,360▲ 55.7%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
27-08
State Gazette act Appointments: BLOMMAERT Dominiek Valère Eduard (non-statutory director) and APHRODITES AMPHORA COSMETICS (managing director)
Permanent representative: BOHE Petruska · Declaration9 facts ▸
  • General meeting, 18-08-2026
  • Director appointment, BLOMMAERT Dominiek Valère Eduard (non-statutory director)
  • Declaration, opzoeking Centraal Register van bestuursverboden, niet opgenomen
  • Board meeting, 18-08-2026
  • Board composition, APHRODITES AMPHORA COSMETICS (director)
  • Board composition, BLOMMAERT Dominiek Valère Eduard (director)
  • Permanent representative, BOHE Petruska (permanent representative)
  • Director appointment, APHRODITES AMPHORA COSMETICS (managing director)
  • Director appointment, APHRODITES AMPHORA COSMETICS (voorzitter van het bestuursorgaan)
27-07
NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
26-08
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema · 26 days late
2024
31-12
Financial Weakest financial yearnet -€2,955
Net result drops to -€2,955, the lowest in the series; recovery starts the following year.
31-12
Financial Equity above €150,000Eq €170,026 ▲16%
Equity rises from €146,622 to €170,026.
26-08
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema · 26 days late
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
1 of 4 acts read
About the unread acts

Of the 4 Belgian State Gazette acts we know for this company, 1 has been read. The other 3 have not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
2 directors, 1 in day-to-day management, last change in 2026

Board 2

APHRODITES AMPHORA COSMETICS
Voorzitter van het bestuursorgaan · since 27-08-2026 · Legal entity · perm. rep.: BOHE Petruska
Current
BLOMMAERT Dominiek Valère Eduard
Non-statutory director · since 27-08-2026
Current

Day-to-day management 1

APHRODITES AMPHORA COSMETICS
Managing director · since 27-08-2026 · Legal entity · perm. rep.: BOHE Petruska
Current

Permanent representatives 1

BOHE Petruska
Permanent representative · since 27-08-2026 · for APHRODITES AMPHORA COSMETICS
Current
Derived from published Gazette acts. The CBE keeps the official list of function holders; we do not read it, so the two can differ. See the function holders in the CBE →
Not every act has been read: a resignation may be missing here
3 of this company's 4 Belgian State Gazette acts have not been read yet. Appointments and resignations recorded in them are missing above: a director who resigned there may therefore still show here as sitting. The acts are in the Timeline.
Location & real-estate footprint
Registered office, Wevelgem · 1 establishment unit since 2022
seat establishment The establishment unit on the map
Ground area
6,118 m²
Building footprint
1,920 m²
Parcel 34302B0875/00Z013, Flanders. Linked by address, not a title deed.
5 companies at this address See who is registered here
1 establishment unit
CONBIN
Vliegveld 43, 8560 WevelgemManufacture of chemicals and chemical products
since 20222.335.467.515
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
34302B0875/00Z013 Flanders 6,118 m² 1 · 1,920 m² -
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Mandate history

2 people since 2026, 2 in office
Show
  • Board
  • Day-to-day management
Mandates per person, with start and end dates
Name Functions and periods
APHRODITES AMPHORA COSMETICS
  • Voorzitter van het bestuursorgaan, from 27-08-2026 to date
  • Managing director, from 27-08-2026 to date
BLOMMAERT Dominiek Valère Eduard
  • Non-statutory director, from 27-08-2026 to date
See the board, name and seat on a given date →

Articles of association

Board rule
Bestuursorgaan, enkel rechtsgeldig beslissen wanneer gedelegeerd bestuurder aanwezig is

Structure & network

Connections & network

2 current directors
Depth

The network starts from this company’s directors. Other companies they run appear here as nodes.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, scroll to zoom.

Similar companies · same sector, comparable size

Of 243 companies in sector 20420 we hold annual accounts for 96. 58 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded25-08-2022
Fiscal year end31-12
Activities, NACEBEL 2025
20420Manufacture of chemicals and chemical products
46450Wholesale of perfume and cosmetics
47750Retail sale of cosmetics and toilet articles
82990Other business support services
E-invoicing
Reachable via Peppol
Peppol ID 0208:0789987992
Also 9925:BE0789987992
Registered 02-01-2026

Register as of 27 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.